News|Articles|April 23, 2026
Predict First Approach - How In Silico Strategies Can Enhance Efficiency in Monoclonal Antibody Bioprocess Development
Author(s)FUJIFILM Biotechnologies
Discover how a “Predict-First” approach uses AI-driven in silico models to de-risk mAb development. See real-case results and a manufacturability scoring framework that accelerates decisions and speeds therapies to market.
Related Content
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
Delaware Governor Meyer on Drug Pricing, Reshoring, and National Security
3
Renewing Prosaic Generics for Cancer Treatment
4
Tom Sellig on CDMO Innovation and US Manufacturing Growth
5